Action Juniper Pharmaceuticals, Inc. - JNP

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

11,50

Prix Achat

11,45

Prix Vente

11,60

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

11,50

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Juniper Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results

Juniper Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results Signs Agreement to be...

WeissLaw LLP Investigates Juniper Pharmaceuticals, Inc.

WeissLaw LLP Investigates Juniper Pharmaceuticals, Inc. PR Newswire NEW YORK, July 5, 2018 NEW YORK, July 5, 2018 /PRNewswire/ -- WeissLaw LLP is...

Juniper (JNP) Alert: Johnson Fistel Investigates Proposed Sale of Juniper Pharmaceuticals, Inc.; Are Shareholders Getting a F...

Juniper (JNP) Alert: Johnson Fistel Investigates Proposed Sale of Juniper Pharmaceuticals, Inc.; Are Shareholders Getting a Fair Deal? PR...

Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash

Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in...

Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results

Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results Core Businesses Driving...

Juniper Pharmaceuticals to Report First Quarter 2018 Results on May 10, 2018

Juniper Pharmaceuticals to Report First Quarter 2018 Results on May 10, 2018 Conference Call Scheduled for...

Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience

Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience -Company Eligible to...

Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors

Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors PR Newswire BOSTON, March 21, 2018...

Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results

Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results Full Year CRINONE® Revenues...

Juniper Pharmaceuticals to Report Fourth Quarter and Year-End 2017 Results on March 8, 2018

Juniper Pharmaceuticals to Report Fourth Quarter and Year-End 2017 Results on March 8, 2018 Conference Call...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

JNP - Frequently Asked Questions (FAQ)

What is the current Juniper Pharmaceuticals, Inc. share price?

The current share price of Juniper Pharmaceuticals, Inc. is US$ 11,50

What is the 1 year trading range for Juniper Pharmaceuticals, Inc. share price?

Juniper Pharmaceuticals, Inc. has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
RTCBaijiayun Group Ltd	US$ 0,4299 (99,95%)	12,44M
COGTCogent Biosciences Inc	US$ 6,79 (59,02%)	3
SMXSMX Security Matters Public Company	US$ 2,29 (56,85%)	6,68M
CFBKCF Bankshares Inc	US$ 32,09 (54,80%)	9
ENTAEnanta Pharmaceuticals Inc	US$ 6,99 (41,78%)	7
TCXTucows Inc	US$ 8,01 (-49,18%)	20
NVNOenVVeno Medical Corporation	US$ 1,25 (-47,48%)	101
FULTFulton Financial Corporation	US$ 9,01 (-43,58%)	11
BFINBankFinancial Corporation	US$ 6,77 (-42,43%)	18
TBLDThomburg Income Builder Opportunities Trust	US$ 10,01 (-42,11%)	7
STSSSharps Technology Inc	US$ 0,034 (28,30%)	25,55M
RTCBaijiayun Group Ltd	US$ 0,4299 (99,95%)	12,44M
GWAVGreenwave Technology Solutions Inc	US$ 0,237 (7,14%)	11,41M
DMNDamon Inc	US$ 0,0037 (19,35%)	11,04M
SUNESUNation Energy Inc	US$ 0,0193 (-1,53%)	7,75M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Juniper Pharmaceuticals, Inc. (delisted) (JNP)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

JNP Dernières nouvelles

Juniper Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results

WeissLaw LLP Investigates Juniper Pharmaceuticals, Inc.

Juniper (JNP) Alert: Johnson Fistel Investigates Proposed Sale of Juniper Pharmaceuticals, Inc.; Are Shareholders Getting a F...

Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash

Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results

Juniper Pharmaceuticals to Report First Quarter 2018 Results on May 10, 2018

Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience

Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors

Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results

Juniper Pharmaceuticals to Report Fourth Quarter and Year-End 2017 Results on March 8, 2018

JNP - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Juniper Pharmaceuticals, Inc. (delisted) (JNP) Cours

Juniper Pharmaceuticals, Inc. (delisted) (JNP)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

JNP Dernières nouvelles

Juniper Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results

WeissLaw LLP Investigates Juniper Pharmaceuticals, Inc.

Juniper (JNP) Alert: Johnson Fistel Investigates Proposed Sale of Juniper Pharmaceuticals, Inc.; Are Shareholders Getting a F...

Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash

Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results

Juniper Pharmaceuticals to Report First Quarter 2018 Results on May 10, 2018

Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience

Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors

Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results

Juniper Pharmaceuticals to Report Fourth Quarter and Year-End 2017 Results on March 8, 2018

JNP - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS